Motavizumab
Top View
- © Copyright 2018 Dennis Ryan Goulet
- A Randomized Controlled Trial of Motavizumab Versus Palivizumab
- Who Drug Information
- Structure Basis of Neutralization by a Novel Site II/IV Antibody Against Respiratory Syncytial Virus Fusion Protein
- Supplementary Tables and Figures Section 1. Distribution of CDR-H3
- Combination AZD7442 Rapidly Advances Into Ph
- Does Respiratory Syncytial Virus Lower Respiratory Illness in Early Life Cause
- Drug Monographs
- Astrazeneca Scales Back Motavizumab
- Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
- Gold Standard Drug Monographs
- Therapeutic Neutralizing Monoclonal Antibodies: Report of a Summit Sponsored by Operation Warp Speed and the National Institutes of Health
- The South East London Red, Amber, Grey (RAG) Medicines List for Adults - Updated January 2020
- Clinicalkey Drug Monographs
- (12) Patent Application Publication (10) Pub. No.: US 2015/0293.086 A1 MESSMER Et Al
- (INN) for Biological and Biotechnological Substances
- Passive Immunoprophylaxis Against Respiratory Syncytial Virus in Children: Where Are We Now?
- Standouts Melanoma Drug Yervoy, with Seemingly Better Tolerability